Skip to main content

Home
Specialties
Resources

Search Videos and More

search

Channel Categories

Breast Cancer (5)
Cancer Screening and Survivorship (4)
Cell Therapy (4)
Clinical Trials (1)
Gastrointestinal Cancer (15)
Genitourinary Cancer (6)
Gynecologic Oncology (6)
Head and Neck Cancer (6)
Hematologic Oncology (7)
Immunotherapy (4)
Neuro-Oncology (4)
Pediatric Hematology/Oncology (3)
Primary Care (4)
Radiation Oncology (5)
Skin Cancer (4)
Surgical Oncology (1)
Thoracic Cancer (5)
Young Adult Malignancies (2)

Types

News (15)

Showing 1 - 12 of 15 results

Previous| 1 | 2 |Next

Roswell Park Study Reveals New Clues to Pancreatic Cancer Spread — and a Possible Way to Stop It

Roswell Park Study Reveals New Clues to Pancreatic Cancer Spread — and a Possible Way to Stop It

Register for Roswell Park’s Fall Oncology Symposium

Register for Roswell Park’s Fall Oncology Symposium

Roswell Park is Hiring!

Roswell Park is Hiring!

Join Roswell Park Experts for Our Quarterly Oncology Symposium May 7

Join Roswell Park Experts for Our Quarterly Oncology Symposium May 7

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025

Roswell Park Reports Extraordinary Outcomes for Robot-Assisted Minimally Invasive Esophagectomy

Roswell Park Reports Extraordinary Outcomes for Robot-Assisted Minimally Invasive Esophagectomy

Join Roswell Park's Experts at NCCN

Join Roswell Park's Experts at NCCN

Join Roswell Park’s Surgical Experts at SSO

Join Roswell Park’s Surgical Experts at SSO

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

$Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers Leads to Clinical Study in Refractory GI Cancers$ News

Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers Leads to Clinical Study in Refractory GI Cancers

Pathways Study Genotype Data, Alliance A011502 Secondary Analysis Headline Roswell Park ASCO24 Presentations

Pathways Study Genotype Data, Alliance A011502 Secondary Analysis Headline Roswell Park ASCO24 Presentations

Showing 1 - 12 of 15 results

Previous| 1 | 2 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer